Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Indian (NIFTY) Clinical Research and Equipment Industry Analysis

UpdatedAug 12, 2026
DataAggregated Company Financials
Companies22
  • 7D3.9%
  • 3M20.0%
  • 1Y26.7%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has remained flat, although notably Tarsons Products declined by 8.3%. The past year has been better, since the industry has gained 22% in that time. Looking forward, earnings are forecast to grow by 22% annually.

Industry Valuation and Performance

Has the Indian Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 12 Aug 2026₹4.0t₹373.0b₹49.0b40.7x80.8x10.6x
Fri, 10 Jul 2026₹3.3t₹361.8b₹46.4b40.5x71.9x9.2x
Sun, 07 Jun 2026₹3.3t₹362.2b₹46.4b37x70.1x9x
Tue, 05 May 2026₹3.2t₹350.8b₹45.9b36.5x70.5x9.2x
Thu, 02 Apr 2026₹2.8t₹350.2b₹46.2b27.8x61.3x8.1x
Sat, 28 Feb 2026₹3.0t₹350.2b₹46.2b27.1x64.8x8.6x
Mon, 26 Jan 2026₹2.8t₹342.6b₹47.1b29.3x60.4x8.3x
Wed, 24 Dec 2025₹3.2t₹342.6b₹48.4b33.1x65.2x9.2x
Fri, 21 Nov 2025₹3.1t₹342.5b₹48.4b33.7x64.2x9.1x
Sun, 19 Oct 2025₹3.3t₹331.4b₹45.5b43x71.5x9.8x
Tue, 16 Sep 2025₹3.2t₹331.4b₹45.5b49.3x70.1x9.6x
Thu, 14 Aug 2025₹3.2t₹329.6b₹45.1b40.9x70x9.6x
Sat, 12 Jul 2025₹2.9t₹300.7b₹37.2b45x78.5x9.7x
Mon, 09 Jun 2025₹2.8t₹299.7b₹37.2b45.8x75.7x9.4x
Wed, 07 May 2025₹2.6t₹289.3b₹30.9b45.1x84.6x9.1x
Fri, 04 Apr 2025₹2.6t₹287.4b₹30.8b47.4x83.9x9x
Sun, 02 Mar 2025₹2.4t₹287.4b₹30.8b44.4x76.8x8.2x
Tue, 28 Jan 2025₹2.3t₹270.2b₹30.4b46.6x77.3x8.7x
Thu, 26 Dec 2024₹2.5t₹269.1b₹30.1b48.9x82.5x9.2x
Sat, 23 Nov 2024₹2.4t₹254.2b₹28.8b49.1x83x9.4x
Mon, 21 Oct 2024₹2.4t₹247.6b₹26.3b52.8x92.9x9.9x
Wed, 18 Sep 2024₹2.3t₹247.6b₹26.3b50.4x87.7x9.3x
Fri, 16 Aug 2024₹1.9t₹205.2b₹23.8b35x77.7x9x
Sun, 14 Jul 2024₹1.8t₹202.0b₹23.9b38.9x75x8.9x
Tue, 11 Jun 2024₹1.7t₹194.7b₹21.5b33.1x80.2x8.9x
Thu, 09 May 2024₹1.4t₹168.0b₹18.7b29.3x77x8.6x
Sat, 06 Apr 2024₹1.4t₹168.5b₹18.6b28.6x76.7x8.5x
Mon, 04 Mar 2024₹1.4t₹168.5b₹18.6b32.5x73.4x8.1x
Wed, 31 Jan 2024₹1.4t₹166.5b₹18.9b30.4x72.4x8.2x
Fri, 29 Dec 2023₹1.4t₹155.9b₹18.1b21.9x78.8x9.1x
Sun, 26 Nov 2023₹1.4t₹155.9b₹18.1b22.6x77x8.9x
Tue, 24 Oct 2023₹1.3t₹156.1b₹19.8b23.9x65.2x8.3x
Thu, 21 Sep 2023₹1.4t₹154.7b₹19.7b24.5x71.8x9.1x
Sat, 19 Aug 2023₹1.4t₹154.7b₹19.7b26.6x70.2x8.9x
Price to Earnings Ratio

70.2x


Total Market Cap: ₹1.4tTotal Earnings: ₹19.7bTotal Revenue: ₹154.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Indian Clinical Research and Equipment Industry Price to Earnings3Y Average 74.8x202420252026
Current Industry PE
  • Investors are optimistic on the Indian Life Sciences Tools and Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 78.4x which is higher than its 3-year average PE of 74.8x.
  • The 3-year average PS ratio of 9.0x is lower than the industry's current PS ratio of 10.3x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have grown 36% per year over the last three years.
  • Revenues for these companies have grown 34% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Indian Clinical Research and Equipment compare with similar industries?

IN Market0.30%
Healthcare1.05%
Life Sciences3.87%
Clinical Research and Equipment3.87%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
DIVISLAB Divi's Laboratories₹8.58k2.4%
+₹53.2b		43.9%PE77.9x
ANTHEM Anthem Biosciences₹891.658.8%
+₹40.8b		19.9%PE87.2x
SAILIFE Sai Life Sciences₹1.44k5.7%
+₹16.5b		64.7%PE84.7x
AKUMS Akums Drugs and Pharmaceuticals₹760.9514.0%
+₹14.3b		58.2%PE39.9x
530239 Suven Life Sciences₹340.059.6%
+₹7.8b		44.2%PS1017.5x

Latest News

AKUMS
₹760.95
Akums Drugs and Pharmaceuticals
7D
14.0%
1Y
58.2%
Analysis Article • 4h

Earnings Beat: Akums Drugs and Pharmaceuticals Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Shareholders of Akums Drugs and Pharmaceuticals Limited ( NSE:AKUMS ) will be pleased this week, given that the stock...
TARSONS
₹297.20
Tarsons Products
7D
-8.3%
1Y
-17.4%
BROOKS
₹59.51
Brooks Laboratories
7D
-2.1%
1Y
-60.0%
SAILIFE
₹1,444.40
Sai Life Sciences
7D
5.7%
1Y
64.7%
Narrative Update • Aug 10

SAILIFE: Upcoming Board Review And Updated Assumptions Will Shape Measured Outlook

Analysts have lifted their price target on Sai Life Sciences from ₹1,275 to about ₹1,369, citing updated assumptions around revenue growth, discount rate, profit margin and future P/E that feed into their fair value models. What’s in the News for Sai Life Sciences Sai Life Sciences has scheduled a board meeting for August 6, 2026.
INNOVACAP
₹1,018.90
Innova Captab
7D
8.2%
1Y
11.8%
DIVISLAB
₹8,578.50
Divi's Laboratories
7D
2.4%
1Y
43.9%
Narrative Update • Aug 06

DIVISLAB: Elevated Future P/E Will Continue To Signal Overvaluation Risk

Analysts have nudged their fair value estimate for Divi's Laboratories higher from ₹5,610 to ₹6,000, citing a slightly lower discount rate, modestly adjusted revenue growth assumptions, and a small improvement in expected profit margins and future P/E levels. What's in the News for Divi's Laboratories Board meeting scheduled on May 23, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
544184
₹136.25
Borosil Scientific
7D
-6.6%
1Y
-5.8%
530239
₹340.05
Suven Life Sciences
7D
9.6%
1Y
44.2%
INDGN
₹567.60
Indegene
7D
2.5%
1Y
-1.2%
Analysis Article • Aug 03

Indegene Limited (NSE:INDGN) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

It's been a good week for Indegene Limited ( NSE:INDGN ) shareholders, because the company has just released its latest...
SYNGENE
₹407.25
Syngene International
7D
-0.7%
1Y
-37.2%
ONESOURCE
₹1,598.90
OneSource Specialty Pharma
7D
4.5%
1Y
-15.8%
Analysis Article • Jul 29

Analysts Are Updating Their OneSource Specialty Pharma Limited (NSE:ONESOURCE) Estimates After Its First-Quarter Results

It's been a good week for OneSource Specialty Pharma Limited ( NSE:ONESOURCE ) shareholders, because the company has...
ANTHEM
₹891.65
Anthem Biosciences
7D
8.8%
1Y
19.9%
New Narrative • Jul 28

Capacity Expansion And Modalities Shift Will Support Stronger Long-Term Earnings Visibility

Catalysts About Anthem Biosciences Anthem Biosciences is a contract research, development and manufacturing organization with a large focus on CRDMO services and specialty ingredients across small molecules, peptides, fermentation and related modalities. What are the underlying business or industry changes driving this perspective?
540729
₹21.75
Vanta Bioscience
7D
-4.7%
1Y
-19.4%
FABTECH
₹147.64
Fabtech Technologies
7D
-2.6%
1Y
n/a